Catasys (CATS) Stock Rating Lowered by Zacks Investment Research

Zacks Investment Research downgraded shares of Catasys (NASDAQ:CATS) from a hold rating to a sell rating in a research note published on Thursday morning.

According to Zacks, “Catasys, Inc., formerly known as Hythiam, Inc., provides specialized behavioral health management services to health plans, employers and unions through a network of licensed and company managed health care providers. The Company’s program seeks to improve member health by delivering medical and psychosocial interventions in combination with long term care coaching, including their proprietary treatment program for alcoholism and stimulant dependence. Catasys, Inc. is based in Los Angeles. “

Catasys (NASDAQ:CATS) traded down $0.19 during trading hours on Thursday, hitting $4.69. 42,144 shares of the stock were exchanged, compared to its average volume of 75,295. Catasys has a twelve month low of $3.30 and a twelve month high of $14.00.

Catasys (NASDAQ:CATS) last posted its quarterly earnings data on Wednesday, March 7th. The company reported ($0.17) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.09) by ($0.08). The firm had revenue of $3.04 million for the quarter, compared to analyst estimates of $3.00 million. analysts forecast that Catasys will post -0.58 EPS for the current year.

A hedge fund recently bought a new stake in Catasys stock. Weber Alan W acquired a new stake in Catasys, Inc. (NASDAQ:CATS) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 108,165 shares of the company’s stock, valued at approximately $406,000. Weber Alan W owned about 0.68% of Catasys at the end of the most recent reporting period. Institutional investors and hedge funds own 4.68% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: “Catasys (CATS) Stock Rating Lowered by Zacks Investment Research” was originally posted by Sports Perspectives and is owned by of Sports Perspectives. If you are accessing this piece of content on another publication, it was illegally stolen and republished in violation of U.S. & international copyright & trademark law. The legal version of this piece of content can be accessed at

Catasys Company Profile

Catasys, Inc provides data analytics based specialized behavioral health management and integrated treatment services to health plans and other third party payors. It offers OnTrak solution to improve treatment outcomes and lower the utilization of medical and behavioral health plan services. The company’s OnTrak solution includes medical and psychosocial interventions; and a proprietary Web based clinical information platform and database, psychosocial programs, and integrated care coaching services.

Get a free copy of the Zacks research report on Catasys (CATS)

For more information about research offerings from Zacks Investment Research, visit

Receive News & Ratings for Catasys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Catasys and related companies with's FREE daily email newsletter.

Leave a Reply